|
|
News Breaks | | | | March 19, 2013 | | 08:52 EDT |  | CAH, WAG | Cardinal Health announces agreement with Walgreen to end in August
Cardinal Health (CAH) announced that its pharmaceutical distribution contract with Walgreen (WAG) which is scheduled to expire at the end of August, will not be renewed. Based on this, the company targets a 2014 non-GAAP diluted earnings per share from continuing operations to be at least similar to the fiscal year 2013 guidance range of $3.42-$3.50. FY14 EPS consensus of $3.81. The company also noted that earnings for the current fiscal year 2013 would not be negatively impacted as the current Walgreens agreement remains in place throughout fiscal 2013. Sales to Walgreens generated approximately 21% of consolidated revenue for fiscal 2012. | |
|
News For CAH;WAG From The Last 14 Days Check below for free stories on CAH;WAG the last two weeks. |
|
|
| June 17, 2013 | | 09:02 EDT |  | WAG | Omnicare, Walgreen's should not see margin falloff, says UBS
 Subscribe for More Information | | | June 12, 2013 | | 10:33 EDT |  | CAH | Cardinal Health management to meet with Cleveland Research
Meeting to be held in Denver on June 14 hosted by Cleveland Research. | | | 07:08 EDT |  | WAG | Drugstores ready access changes to Plan B pill, WSJ reports
Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, reports the Wall Street Journal.Reference Link | | | 06:05 EDT | | WAG | On the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: The tectonic plates of the world economy are shifting, moving the yield on the 10-year Treasury to the highest level in more than a year and shaking financial markets. Now, some constants are being questioned in markets, triggering paroxysms in stocks, bonds, commodities and the currencies of emerging markets, the Wall Street Journal reports...Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, the Wall Street Journal reports...REUTERS: If currency turbulence in emerging markets becomes a full-scale investor flight, the Fed may have a new headache in deciding when to slow its dollar printing policy. The link between U.S. monetary policy and currency runs on the other side of the world could be tighter than many assume, Reuters reports...Toyota Motor (TM) said it’s unlikely to recapture its peak market share it held four years ago in the U.S. (GM, F), its biggest market, the latest sign the carmaker is shifting to improving quality from aggressively expanding sales, Reuters reports...BLOOMBERG: Exchange executives (NYX, NDAQ), long shielded from legal scrutiny in the U.S., have been put on notice that may be changing after federal regulators fined CBOE Holdings (CBOE) $6M for unprecedented lapses in supervision, Bloomberg reports...Borealis Infrastructure Management and its Kuwaiti-British partners abandoned their $8.3B bid for the U.K. water utility Severn Trent (SVTRY) as the offer deadline expired, Bloomberg reports. | | | June 11, 2013 | | 17:02 EDT | | WAG | Walgreens reaches agreement with the DEA and Department of Justice
Subscribe for More Information | | | 15:10 EDT | | WAG | Walgreens to pay $80M in penalties to settle pain killer distribution charges
The Drug Enforcement Administration, Miami Field Division, and the United States Attorney for the Southern District of Florida announced that Walgreens has agreed to pay $80M in civil penalties, resolving the DEA’s administrative actions and the U.S. Attorney’s Office’s civil penalty investigation regarding the Walgreens Jupiter Distribution Center and six Walgreens retail pharmacies in Florida. The settlement, the largest in DEA history, resolves allegations that the registrants committed an unprecedented number of record-keeping and dispensing violations under the Act. According to documents filed in the underlying administrative actions, the registrants negligently allowed controlled substances listed in Schedules II – V of the Act, such as oxycodone and other prescription pain killers, to be diverted for abuse and illegal black market sales. | | | June 5, 2013 | | 08:30 EDT |  | WAG | Walgreen overall volatility at one-year high into Q3 and outlook
Subscribe for More Information | | | 08:05 EDT | | WAG | Walgreen reports May sales up 4.3% to $6.22B
Subscribe for More Information | | | June 3, 2013 | | 17:22 EDT | | CAH | Cumberland expands agreement with Cardinal Health
Cumberland (CPIX) disclosed in a regulatory filing that on May 28, the company extended the term of an exclusive distribution agreement with Cardinal Health (CAH) through June 30, 2016 and revises the fee schedule under the agreement. The agreement and amendment appoint Cardinal Health as the exclusive distribution agent for Acetadote, Caldolor and Kristalose in the United States, Puerto Rico and other countries. Under the amendment, Cumberland engages Cardinal to assist with its physician sample orders based on the Prescription Drug Marketing Act of 1987 for samples shipping. The amendment also extends the initial term through June 30, 2016 and it remains terminable by either party upon 120 days notice. After June 30, 2016, the contract is automatically renewed on a year-to-year basis that is terminable by either party with ninety days notice. | |
|
|
|
|
|
|
